![]() | Only 14 pages are availabe for public view |
Abstract HCC is the commonest primary tumour of the liver.There is increase in the rate of incidence of HCC in the world.HCC is the 3rd common cancer in males.It is the 5th common cancer in females. There is increase in the incidence of HCC in Egypt.This may be due to increased exposure to risk factors e.g HBV , HCV and liver cirrhosis. * The risk factors to HCC are multiple and may include:liver cirrhosis , chronic HBV infection , chronic HCV infection , hereditary haemochromatosis , hereditary tyrosinemia , autoimmune hepatitis , nonalcoholic steatohepatitis and other risk factors. *The common symptoms due to HCC may be abdominal pain , malaise , anorexia , nausea , vomiting , variceal bleeding , loss of weight and jaundice. The common signs due to HCC may be hepatomegaly , jaundice , hepatic bruit , ascitis , splenomegaly .There may be spontaneous bacterial peritonitis , metastasis , paraneoplastic syndrome e.g diarrhea , erythrocytosis , hypoglycemia or carcinoid syndrome. * The screening to HCC could be done by s.AFP alone or imaging methods alone e.g US , CT , MRI or a combination of s. AFP and imaging methods. 101 *The diagnosis of HCC should include the following: 1-serum HCC tumour markers:e.g s.AFP or s. DCP . s. AFP > 400 ng/ml is diagnostic of HCC. 2-Imaging methods:e.g US , CT , MRI , scintigraphy or angiographic imaging. US can be used in combination with s. AFP to screen to HCC.These imaging methods can detect vascular invasion of HCC. 3-PANB. 4-Assesment of the liver functions:It could be done by the Child-Pugh scoring system or by the Model for End Stage Liver Disease scoring system. * There are diferrent staging systems to HCC e.g BCLC , CLIP , Okuda or TNM staging systems. There are different treatment options to HCC e.g tumour resection , liver transplantation , PEI , RFA , TACE , antineoplastic drugs or symptomatic treatment. 102 *Treatment :There are different treatment options to HCC e.g 1-Tumour resection:It may be a curative treatment to HCC. it is recommended to few number of patients with HCC because most of patients with HCC have advanced liver disease and/or decreased liver function. After HCC resection , relapse may occur. relapse may be due to the resected tumour was incompletely treated at the first time or a second tumour not related to the first tumour occurred in the liver. 2-Liver transplantation:May be considered in any patient with liver cirrhosis and HCC single nodule < 5 cm or 3 nodules < 3 cm. 103 *The success of liver transplantation has increased steadily over the last two decades and several advances have been made since the first human liver transplantation. This procedure has become routine with an excellent outcome in both quality and length of life. *The result of liver transplantation has improved due to advances in preoperative techniques, abetter understanding of the cause and prognosis of several liver diseases and more effective in post-operative care. *Overall, liver transplant recipients enjoy a good quality of life and often return to employment. Female recipients are allowed pregnancy and the risk is generally small. This evolution is mainly the result of standardization of the technique and improved patient. * Liver regeneration occurs rapidly after transplantation .A study using serial MRI measurements showed that donor and recipient mass increased by 144% and 99%, respectively, by 2 months. Regeneration appears to be greatest in the first week, using CT scans to assess liver regeneration in recipients and donors found an increase in donor and recipient liver size of 42% ± 26% vs. 86% ± 11%,67% ± 41% vs. 120% ± 27%, and 74% ± 46% vs. 75% ± 37% at 1,2, and 6 months, respectively. The overall the rate of growth was greater of the recipient than donor (Terrault NA .2002). |